| __timestamp | Amgen Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 13673000 |
| Thursday, January 1, 2015 | 4070000000 | 14358000 |
| Friday, January 1, 2016 | 3840000000 | 12203000 |
| Sunday, January 1, 2017 | 3562000000 | 18125000 |
| Monday, January 1, 2018 | 3737000000 | 17071000 |
| Tuesday, January 1, 2019 | 4116000000 | 20018000 |
| Wednesday, January 1, 2020 | 4207000000 | 32788000 |
| Friday, January 1, 2021 | 4819000000 | 44966000 |
| Saturday, January 1, 2022 | 4434000000 | 311681000 |
| Sunday, January 1, 2023 | 4784000000 | 77707000 |
| Monday, January 1, 2024 | 5964000000 |
Data in motion
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Amgen Inc. and Lantheus Holdings, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Amgen consistently allocated substantial resources, with an average annual R&D expenditure of approximately $4.2 billion. This commitment underscores Amgen's dedication to pioneering advancements in biotechnology.
Conversely, Lantheus Holdings, Inc. exhibited a more conservative approach, with R&D spending averaging around $56 million annually. Notably, 2022 marked a significant spike for Lantheus, with a 450% increase compared to its 2014 spending, reflecting a strategic pivot towards innovation. This divergence in R&D investment strategies highlights the varied paths companies take in the pursuit of scientific breakthroughs and market leadership.
Analyzing R&D Budgets: Novartis AG vs Amgen Inc.
Research and Development: Comparing Key Metrics for Amgen Inc. and Intra-Cellular Therapies, Inc.
Gross Profit Trends Compared: Amgen Inc. vs Lantheus Holdings, Inc.
Comparing Innovation Spending: Amgen Inc. and Opthea Limited
Amgen Inc. or Travere Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: argenx SE vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Genmab A/S vs Lantheus Holdings, Inc.
Research and Development Investment: Lantheus Holdings, Inc. vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Mesoblast Limited
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.